Recently, Huang and colleagues suggested that the nuclear factor κB-inhibitor α (NFKBIA), an inhibitor of the NF-κB transcription factor, which is implicated in the progression of pancreatic cancer, is a target of the miR-196a in PDAC [48]. Here, NFKBIA is linked to pancreatic neoplasm.